For the Inventor, By the Inventor

Enter assignee name

Tustin, CA, United States of America

Peregrine Pharmaceuticals, Inc.

USPTO Granted Patents = 10

CIPO Patents = 3

EPO Patents = 3

Trademarks = 2

Forward Citations = 59

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Anita Kavlie (3 out of 20 patents)

Kyle Schlunegger (3 out of 3 patents)

Steven W King (3 out of 8 patents)

4. Philip E Thorpe (2 out of 63 patents)

5. Raimo Pellikka (2 out of 2 patents)

6. Peter Bläuenstein (2 out of 2 patents)

7. Pius A Schubiger (2 out of 2 patents)

8. Yveta Germano (2 out of 2 patents)

9. Shelley P M Fussey (1 out of 1 patent)

10. Troy A Luster (1 out of 1 patent)

11. Andrew James Williams (1 out of 6 patents)

12. Philip Ronald Tempest (1 out of 19 patents)

13. Thor Las Holtet (1 out of 2 patents)

14. Helen Jackson (1 out of 2 patents)

15. Alan J Schroit (1 out of 8 patents)

10 patents: Sort by Forward Citations

1. 9835626 - Methods and compositions for isolating exosomes (2017-12-05),

2. 9421256 - Anti-VEGF antibody compositions and methods (2016-08-23),

3. 8956616 - Constructs binding to phosphatidylserine and their use in disease treatment (2015-02-17),

4. 8394943 - Anti-VEGF antibody compositions and methods (2013-03-12),

5. 8137540 - Methods and apparatus for continuous large-scale radiolabeling (2012-03-20),

6. 8034905 - Anti-VEGF antibody compositions and methods (2011-10-11),

7. 7605234 - Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof (2009-10-20),

8. 7591953 - Methods and apparatus for continuous large-scale radiolabeling of proteins (2009-09-22),

9. 6255291 - Composition and method for treating cancer and immunological disorders resulting in chronic conditions (2001-07-03),

10. 5879880 - Method of diagnosing by determining formic acid to nicotinic acid ratio (1999-03-09),

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of innovative cancer therapies. With a strong pipeline of targeted monoclonal antibodies and immunotherapies, Peregrine is committed to advancing treatments for patients with unmet medical needs. Through strategic partnerships and collaborations, Peregrine is working towards improving outcomes for cancer patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

10 Patents

#17 in Tustin, CA

#6,897 in California

#29,016 in US

#54,348 in the World

Tustin, CA, United States of America

Peregrine Pharmaceuticals, Inc.

Forward Citations = 59

17 inventors:

Anita Kavlie (3 out of 20 patents)

Kyle Schlunegger (3 out of 3 patents)

Steven W King (3 out of 8 patents)

4. Philip E Thorpe (2 out of 63 patents)

5. Raimo Pellikka (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…